Status
Conditions
Treatments
About
The primary study objective is to evaluate if personalized treatment by decision support, based on the biomarker-based risk prediction (ABC-scores) guided strategy, reduces the occurrence of the composite outcome of stroke or death in patients with atrial fibrillation. Approximately 6500 patients will be randomized 1:1 to ABC risk score guided therapy or standard care.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
3,933 participants in 2 patient groups
Loading...
Central trial contact
Ziad Hijazi, MD, PhD; Christina Björklund
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal